Evidence map›Paper›PMID 30906145›Full record

ArticleJournal of pharmacy & bioallied sciences

Appropriateness of Acid-suppressing Agents for Stress Ulcer Prophylaxis in Non-intensive Care Unit Setting in Saudi Arabia.

Ala Malhis, Taghreed Alghamdi, Reem Alfandi, Zahra AlHaj Issa, Hadeel Alanazi, Hend Alfintoukh, Jaffer Bin Baqar, Sheraz Ali

Open access · goldAbstract read
In one paragraph

Article in Journal of pharmacy & bioallied sciences. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Assessment of adherence to the national stress ulcer prophylaxis guidelines: A cross-sectional analysis.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2023
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Ala MalhisPharmaceutical Care Services, King Saud Medical City, Ministry of Health, Riyadh, Kingdom of Saudi Arabia.
Taghreed AlghamdiPharmaceutical Care Services, King Saud Medical City, Ministry of Health, Riyadh, Kingdom of Saudi Arabia.
Reem AlfandiEmergency Department, King Saud Medical City, Ministry of Health, Riyadh, Kingdom of Saudi Arabia.
Zahra AlHaj IssaDepartment of Internal Medicine, King Fahad Medical City, Ministry of Health, Riyad, Kingdom of Saudi Arabia.
Hadeel AlanaziPharmaceutical Care Services, King Saud Medical City, Ministry of Health, Riyadh, Kingdom of Saudi Arabia.
Hend AlfintoukhPharmaceutical Care Services, King Saud Medical City, Ministry of Health, Riyadh, Kingdom of Saudi Arabia.
Jaffer Bin BaqarDepartment of Statistics, University of Karachi, Karachi, Pakistan.
Sheraz AliPharmaceutical Care Services, King Saud Medical City, Ministry of Health, Riyadh, Kingdom of Saudi Arabia.
Ministry of Health · SAKing Saud Medical City · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the appropriateness of acid-suppressive therapy (AST) for stress ulcer prophylaxis (SUP) in noncritically ill hospitalized patients. MATERIALS AND

methodsA prospective, observational study with 384 subjects was conducted between October and December 2017 in the emergency and internal medicine departments. The Herzig clinical risk scoring system and the guidelines of the American Society of Health-System Pharmacists guidelines were used to assess risk factors and determine risk scores for gastrointestinal (GI) bleeding.

resultsThe mean age of subjects was 51.9 ± 19.4 years, and 220 (57.3%) of them were males. Among the absolute risk factors, coagulopathy was observed in 2 (0.5%) patients, mechanical ventilation in 15 (3.9%), and a history of GI bleeding in 1 (0.3%). Of 384 patients with SUP, 370 (96.4%) had a clinical risk score ≤ 9 and 14 (3.6%) had a risk score between 10 and 12 for nosocomial GI bleeding. A statistically significant relationship was found between the risk factor indication and demographics.

conclusionSUP is frequently administered to noncritically ill hospitalized patients lacking risk factors for GI bleeding. Proton pump inhibitors are the overwhelming first choice of AST among prescribers. Practitioners should follow international guidelines when prescribing ASTs outside the critical-care setting.

Indexed as

Acid-suppressing agentprophylaxisstress ulcer

Identifiers

PMID30906145
PMCPMC6394160
OpenAlexW2914758165

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.